U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07305116) titled 'CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease' on Nov. 30.
Brief Summary: CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated autoimmune disease.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Autoimmune Diseases
Systemic Lupus Erthematosus (SLE)
Multi-Drug Resistant Nephrotic Syndrome
IgA Nephropathy (IgAN)
Systemic Sclerosis (SSc)
ANCA Associated Systemic Vasculitis
Intervention:
BIOLOGICAL: UCAR T-cell
Universal allogeneic anti-CD19/BCMA CAR T-cells.
Recruitment Status: RECRUITING
Sponsor: The Children's Hospital of Zhejiang Univ...